Journalists Wandering Eyes Posted May 19, 2023 Journalists Posted May 19, 2023 In its February 20th meeting, the Racing Medication and Testing Consortium's (RMTC) Board of Directors approved a recommendation from its Scientific Advisory Committee (SAC) to designate a 4/B classification for the substance Mofebutazone.View the full article Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.